Showing results (71-80 of 167) with videos related to
Sort By:
Pageof 17
Diabetes Care|September 30, 2003
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trialAnthony Keech, David Colquhoun, James Best, et al.Journal of Medical Genetics|October 25, 2014
Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disabilityDavid Hunt, Richard J Leventer, Cas Simons, et al.Journal of Patient Safety|October 22, 2016
Measuring Patient Safety: The Medicare Patient Safety Monitoring System (Past, Present, and Future)David C Classen, William Munier, Nancy Verzier, et al.The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 25, 2024
Environmental Enrichment and Health Outcomes Among Low-Grade Glioma Brain Tumor SurvivorsKarl Cristie F Figuracion, Christine Mac Donald, David Hunt, et al.Journal of Huntington'S Disease|April 13, 2025
Asymmetric brain atrophy in Huntington's disease: A postmortem MRI studyEardi Lila, David Hunt, Daniel D Child, et al.Circulation|September 25, 2002
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groupsAndrzej Budaj, Salim Yusuf, Shamir R Mehta, et al.Emerging Infectious Diseases|April 28, 2004
Mycobacterium bovis infection, United KingdomRobert M M Smith, Francis Drobniewski, Andrea Gibson, et al.American Heart Journal|June 20, 2006
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID studyAndrew M Tonkin, Simon Eckermann, Harvey White, et al.Annals of Neurology|September 20, 2020
Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus ErythematosusJames A Varley, Magnus Andersson, Eleanor Grant, et al.American Heart Journal|March 20, 2012
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyAndrew Tonkin, David Hunt, Merryn Voysey, et al.Pageof 17